Welcome to our dedicated page for Celularity SEC filings (Ticker: CELUW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Celularity Inc.'s SEC filings document material events for a regenerative and cellular medicine company with listed common stock and public warrants, including CELUW. The filings describe warrant terms exercisable for one-tenth of a share of Class A common stock, capital-structure disclosures, material agreements, and operating and financial results.
Recent Form 8-K disclosures also cover governance and executive-compensation matters, finance leadership changes, clinical or regulatory updates, and shareholder or security-structure matters tied to Celularity's placental-derived cell therapy and biologics business.